Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation

NCT05162456 · clinicaltrials.gov ↗

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV2 Infection
SARS-CoV2 Antibodies

Interventions

DIAGNOSTIC_TEST: assessment of the anti-SARS-CoV-2 IgG antibody titer in 3-dose schedule
DIAGNOSTIC_TEST: assessment of the anti-SARS-CoV-2 IgG antibody titer in 2-dose schedule

Sponsor

Collegium Medicum w Bydgoszczy